These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Sustained response of primary cutaneous CD30 positive anaplastic large cell lymphoma to bexarotene and photopheresis. Sheehy O, Catherwood M, Pettengell R, Morris TC. Leuk Lymphoma; 2009 Aug; 50(8):1389-91. PubMed ID: 19544141 [No Abstract] [Full Text] [Related]
6. Results of a Phase II Trial of Brentuximab Vedotin for CD30+ Cutaneous T-Cell Lymphoma and Lymphomatoid Papulosis. Duvic M, Tetzlaff MT, Gangar P, Clos AL, Sui D, Talpur R. J Clin Oncol; 2015 Nov 10; 33(32):3759-65. PubMed ID: 26261247 [Abstract] [Full Text] [Related]
10. Primary cutaneous CD30 positive anaplastic large cell lymphoma in an adolescent. Vaid R, Cohen B. Pediatr Dermatol; 2009 Nov 10; 26(6):721-4. PubMed ID: 20199449 [Abstract] [Full Text] [Related]
14. [Neutrophil-rich, anaplastic CD30+ T cell lymphoma in conjunction with lymphomatoid papulosis]. Slotosch CM, Hörster S, Hertl M, Schultz E. Hautarzt; 2010 Jun 15; 61(6):511-3. PubMed ID: 19536511 [Abstract] [Full Text] [Related]
15. Loss of expression of 5-hydroxymethylcytosine in CD30-positive cutaneous lymphoproliferative disorders. De Souza A, Tinguely M, Pfaltz M, Burghart DR, Kempf W. J Cutan Pathol; 2014 Dec 15; 41(12):901-6. PubMed ID: 25353265 [Abstract] [Full Text] [Related]
16. Secondary ALK negative anaplastic large cell lymphoma in a patient with lymphomatoid papulosis of 40 years duration. Marschalkó M, Eros N, Holló P, Hársing J, Bottlik G, Bátai A, Csukly Z, Masszi T, Szentirmai Z, Fodor J, Kárpáti S, Matolcsy A, Csomor J. Am J Dermatopathol; 2010 Oct 15; 32(7):708-12. PubMed ID: 20644462 [Abstract] [Full Text] [Related]
20. Primary cutaneous CD30 positive anaplastic large cell lymphoma--report of a case treated with bexarotene. Oliveira A, Fernandes I, Alves R, Lima M, Selores M. Leuk Res; 2011 Nov 15; 35(11):e190-2. PubMed ID: 21764128 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]